Sayer Kevin R's Form 4 filing
Dexcom Inc (DXCM) · filed Jan 17, 2024
- Accession no.
- 0001093557-24-000012
- Filed
- Jan 17, 2024
- Trade date
- Jan 12-16, 2024
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $4.61M. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sayer Kevin RCIK 0001286858 | Director, Officer (President, CEO and Chairman) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 12, 2024 | Common Stock | AGrant or awardAcquired | +72,709 | $0.00 | $0 | 400,166 | Direct | |
| Jan 16, 2024 | Common Stock | SSaleDisposed | −37,325 | $123.63 | −$4,614,489.75 | 362,841 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.